T1	Participants 44 92	in patients insufficiently controlled on timolol
T2	Participants 230 341	in patients with open angle glaucoma or ocular hypertension where IOP is not adequately controlled with timolol
T3	Participants 416 554	53 patients with primary open angle glaucoma, capsular glaucoma, or ocular hypertension with an IOP of at least 21 mmHg on current therapy
